1. ScholarBank@NUS

Eng King Tan

rp09622

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
Main Affiliation
 
Faculty
 
Email
gmstek@nus.edu.sg
 

Publications

Refined By:
Department:  DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)

Results 361-380 of 413 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
361Jul-2009SORL1 haplotypes modulate risk of Alzheimer's disease in ChineseTan, E.K. ; Lee, J.; Chen, C.P. ; Teo, Y.Y.; Zhao, Y.; Lee, W.L. 
22008Spectrum of anxiety symptoms in hyperkinesiasTan E.-K. ; Chan L.-L. 
32000Spinocerebellar ataxia in Singapore: Predictive features of a positive DNA test?Tan E.K. ; Law H.Y.; Zhao Y.; Lim E.; Chan L.L.; Chang H.M.; Ng I.; Wong M.-C.
42017Structural connectome alterations in prodromal and de novo Parkinson's disease patientsWen M.-C. ; Heng H.S.E.; Hsu J.-L.; Xu Z.; Liew G.M.; Au W.L. ; Chan L.L.; Tan L.C.S. ; Tan E.K. 
52011Sub-clinical hypothyroidism and reversible choreoathetosisHameed S.; Tan E.-K. 
6Feb-2010Summary of GIGYF2 studies in Parkinson's disease: The burden of proofTan, E.K. ; Schapira, A.H.
72017Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondriaXiao B.; Deng X.; Lim G.G.; Xie S. ; Zhou Z.D.; Lim K.-L. ; Tan E.-K. 
482016Susceptibility-weighted MRI of extrapyramidal brain structures in Parkinsonian disordersSchneider E. ; Ng K.-M.; Yeoh C.-S.; Rumpel H. ; Fook-Chong S. ; Li H.-H. ; Tan E.-K. ; Chan L.-L. 
92000Tardive and idiopathic oromandibular dystonia: A clinical comparisonTan E.-K. ; Jankovic J.
102018Targeted exome sequencing reveals homozygous TREM2 R47C mutation presenting with behavioral variant frontotemporal dementia without bone involvementNg A.S.L.; Tan Y.J. ; Yi Z.; Tandiono M.; Chew E.; Dominguez J.; Macas M.; Ng E.; Hameed S. ; Ting S. ; Tan E.K. ; Foo J.N.; Kandiah N. 
112013Targeting leucine-rich repeat kinase 2 in Parkinson's diseaseChan S.L.; Angeles D.C.; Tan E.-K. 
122017Targeting LRRK2 in Parkinson's disease: an update on recent developmentsChan S.L.; Tan E.-K. 
132008Test-retest repeatability of assessing environmental and lifestyle factors in Parkinson's diseaseYip C.-W.; Tan E.-K. 
142008The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinsons disease, levodopa treatment response, and complicationsBialecka M.; Kurzawski M.; Klodowska-Duda G.; Opala G.; Tan E.-K. ; Drozdzik M.
152012The borderland between epilepsy and movement disordersPeeraully T.; Kaji R.; Tan E.-K. 
162005The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patientsTan E.K. ; Shen H.; Tan L.C.S. ; Farrer M.; Yew K.; Chua E.; Jamora R.D.; Puvan K. ; Puong K.Y.; Zhao Y.; Pavanni R. ; Wong M.C. ; Yih Y.; Skipper L.; Liu J.-J. 
171-Dec-2019The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in SingaporeWu, J; Lim, EC; Nadkarni, NV ; Tan, EK ; Kumar, PM 
182016The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: A longitudinal studyPrakash K.M. ; Nadkarni N.V. ; Lye W.-K. ; Yong M.-H.; Tan E.-K. 
192007The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: Genetic and functional evidenceTan E.K. ; Zhao Y.; Skipper L.; Tan M.G.; Di Fonzo A.; Sun L.; Fook-Chong S.; Tang S.; Chua E.; Yuen Y.; Tan L.; Pavanni R.; Wong M.C.; Kolatkar P.; Lu C.S.; Bonifati V.; Liu J.J.
202008The need for appropriate genotyping strategies for glucocerebrosidase mutations in cohorts with Parkinson disease - ReplyTan E.-K.